.png){kind=icon}
Shanghai Location
Our Shanghai team specializes in preclinical pharmaceutical development offering a variety of options for study and molecule types, as well as capacity to accommodate fast and flexible study starts. From Biologics to Immunotoxicology & Immunology to IND-enabling, our global data approach ensures dependable delivery.
Recent Investments & Expansions
现在提供以下增强功能：
- 2x更多的大型动物能力，开始研究
- 符合欧盟的住房选项
- 全服务适用于生物制剂的软件包
- New Immunotoxicology & immunology and cell culture laboratories
- COPD，IBD，肿瘤异种移植，肿瘤，肝炎和纤维化的疾病模型试验
- Connected scientific and regulatory expertise enabling dual filing in the U.S. and China and large molecule IND-enabling studies
总英尺2: 85,000 +
学习室数量：45+
PHDS数量：5+
总就业：140+
Site Stats
Capabilities
专业专业知识
- Preclinical and clinical pharmaceutical development
资格
- Aaalac认可
- 动物住房符合实验动物的护理和使用指南，第8版
- 来自中华人民共和国和经合组织的NMPA的良好实验室实践（GLP）认证。由美国FDA检查
Dose Routes
- Dermal
- IV输液
- 口服：胶囊，牧草
- Parenteral (IM, SC, IV)
The Shanghai R&D Center
The Shanghai R&D Center combines bioanalytical, clinical trial testing and clinical development operations in one convenient location. This experienced team has more than 20 years of experience with Chinese regulations and drug development best-practices.
